For researchers studying these compounds, the key considerations include: Receptor selectivity: How compounds preferentially activate different receptor subtypes Pharmacokinetics: Duration of action and optimal dosing intervals Safety profiles: Understanding gastrointestinal tolerability across compound classes Metabolic endpoints: Effects beyond weight, including liver fat, lipids, and glycemic markers For those interested in studying triple agonist compounds, ARG Peptides offers research-grade GLP-3RT (a GLP-1/GIP/glucagon triple agonist) in various sizes for laboratory research
doi:10.1016/j.ejim.2011.11.013 Guilliams, Thomas G, and Lindsey E Drake
Potaczek, Philipps-University of Marburg, Germany Reviewed by Jiajun Yang, China Agricultural University, China Edward Brell, Australian Self Medication Industry Inc, Australia Lucia Giannini, University of Milan, Italy Updates Copyright 2026 El-Saadony, Saad, Sitohy, Alkafaas, Dladla, Ghosh, Mohammed, Ibrahim, Fahmy, Elkelish, AbuQamar and El-Tarabily
In essence, these drugs help make you feel full and less hungry
Pellerin, L., & Magistretti, P